Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Tips to Prevent Radial Occlusion after Catheterization

The transradial access is the preferred access site for patients undergoing acute coronary syndrome. Compared to the transfemoral access site, it reduces the risk of all cause death, vascular complications and major bleeding.

acceso_radialRadial artery occlusion is the most frequent vascular complication associated to this approach, though it rarely results in clinical consequences such as ischemia, given the dual blood supply to the hand from the radial and ulnar arteries. However, radial artery occlusion becomes a problem when the artery is needed for new catheterization, CABG or dialysis.

 

A meta-analyzis of 66 studies showed that radial artery occlusion rate is 11% with a 6 Fr sheath vs. 2% with a 5Fr sheath. Occlusion rate dropss from 7.7% to 5.5% a week after procedure thanks to spontaneous recanalization. The same study showed that occlusion rate is lower with PCI than with diagnostic studies (4.5% vs. 8.8%; p<0.001), probably due to routine use of antiplatelets and higher doses of anticoagulants.


Read also: Transradial Access and Early Discharge in Percutaneous Interventions.


With this in mind, SCAI suggests a few pharmacological and non-pharmacological measures to prevent occlusion:

 

  • A 5000 UI dose of unfractionated heparin (both intra-arterial and intravenous) effectively prevents radial occlusion. Bivalirudin has shown a similar effect. In case of morbid obesity, we should consider a 50 UI/kg dosage.
  • Spasm prevention with intra-arterial nitroglycerin and a calcium channel blocker, such as verapamil. After procedure and before sheath removal, an additional dose of nitroglycerin reduced the incidence of occlusion, compared against placebo.
  • Minimal sheath-to-artery ratio. Assess left and right radial arteries and choose the one with larger diameter.
  • Ultrasound guided radial access: it reduces the number of attempts and wall trauma, though most cath labs are far from using it daily.

 

  • Compression to get hemostasis but without occluding the artery. Preserving antegrade flow maintaining hemostasis reduces the rate of acute occlusion (12% vs 5%; p<0.05) and occlusion at long term (7% vs 1.8%; p<0.05).
  • Consider simultaneous compression of the ulnar artery to improve radial antegrade flow.
  • A 30-minute compression for diagnostic studies and 90 to 120-minute compressions in therapeutic procedures is enough to get hemostasis.

 

Conclusion

The most important maneuvers to keep artery patency after catheterization are: periprocedural anticoagulation, reducing compression time as much as possible, using the smallest sheath size possible, and using the hemostasis technique maintaining antegrade flow.

 

Título original: Radial Artery Occlusion After Transradial Cardiac Catheterization: Tips on Prevention and Management.

Referencia: Sridevi R. Pitta et al. SCAI’s January 2018 Quality Improvement Toolkit (QIT) Tip.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...